Akiko Masumoto

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1.

Akiko Masumoto, Martin E. Hemler · Journal of Biological Chemistry · 1993 · 261 citations · Full text

Mechanistic Differences, Cell Adhesion Molecule-1, Cell Adhesion +19

Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin.

Akiko Masumoto, Martin E. Hemler · The Journal of Cell Biology · 1993 · 116 citations · Full text

High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.

Atushi Moriyama, Akiko Masumoto, H Nanri et al. · PubMed · 1997 · 51 citations

Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases

Akiko Masumoto, Takeshi Kitai, Shingo Matsumoto et al. · Journal of Cardiology · 2021 · 19 citations · Full text

Long Covid, Cardiovascular Disease, Short-term Prognosis +5